)
Niagen Bioscience (NAGE) investor relations material
Niagen Bioscience Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2025 net sales rose 33% year-over-year to $34.0 million, with Tru NiagenⓇ sales up 44% to $26.0 million, and net income increasing to $4.6 million from $1.9 million last year.
Adjusted EBITDA reached $6.4 million, up 120% year-over-year, and cash provided by operations for the first nine months totaled $12.8 million, ending with $64.3 million in cash and no debt.
Growth was driven by strong e-commerce and distribution channels, with e-commerce net sales up 29% and distribution revenue up 109% year-over-year.
Expanded clinical distribution, with Niagen Plus™ IV and injectable therapies now in over 1,000 clinics nationwide, and launched AboutNAD®, a digital platform for NAD+ research.
Continued focus on scientific validation, with 40+ peer-reviewed studies and ongoing clinical research in long COVID, Parkinson's, and AT.
Financial highlights
Gross margin improved to 64.5% in Q3 2025, up 100 basis points year-over-year, with gross profit at $21.9 million.
Sales and marketing expense as a percentage of net sales improved to 25.8%, down 170 basis points year-over-year.
Operating income for Q3 2025 was $4.2 million, up from $1.6 million in Q3 2024.
Diluted EPS was $0.06 for Q3 2025, up from $0.02 in Q3 2024.
Cash and cash equivalents stood at $64.3 million at quarter end, with no outstanding debt.
Outlook and guidance
Full-year 2025 net sales growth guidance raised to 25%-30% year-over-year, up from previous 22%-27%.
Research and development and general and administrative expenses expected to rise in absolute dollars but decline as a percentage of net sales.
Management expects current cash and cash flow from sales to cover obligations for at least the next twelve months.
Confident in delivering significant shareholder returns in 2026 and beyond.
Next Niagen Bioscience earnings date
Next Niagen Bioscience earnings date
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)